Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Thoracic and Cardiovascular Surgery

• Publication date

  2013-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jtcvs.2012.12.037PMID 23434448
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume.

  2012cited by this paper
• Accuracy of Diagnostic Biopsy for the Histological Subtype of Malignant Pleural Mesothelioma

  2011cited by this paper
• Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.

  2011cited by this paper
• Surgical assessment of malignant pleural mesothelioma: have we reached a critical stage?

  2010cited by this paper
• Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases

  2010cited by this paper
• Characteristics of malignant pleural mesothelioma in women.

  2010cited by this paper
• Recent advances in mesothelioma staging.

  2009cited by this paper
• A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma.

  2009cited by this paper
• Radiation therapy options for malignant pleural mesothelioma.

  2009cited by this paper
• Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.

  2009cited by this paper
• Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesothelioma

  2006cited by this paper
• Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.

  2006cited by this paper
• Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma.

  2006cited by this paper
• Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma.

  2004cited by this paper
• Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

  2003cited by this paper
• Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis.

  2002cited by this paper
• Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.

  1999cited by this paper
• Histological Typing of Lung and Pleural Tumours

  1999cited by this paper
• Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study.

  1999cited by this paper
• Patterns of failure after trimodality therapy for malignant pleural mesothelioma.

  1997cited by this paper
• A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.

  1995cited by this paper
• High doses of intrapleural cisplatin in a case of malignant pleural mesothelioma. Clinical observations and pharmacokinetic analyses

  1994cited by this paper
• Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma.

  1993cited by this paper
• Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.

  1992cited by this paper
• Analysis of survival by tumor response.

  1983cited by this paper

• Present and future of cytoreductive surgery and hyperthermic intrathoracic chemotherapy for pleural metastases: a narrative review.

  2026cites this paper
• Intrathoracic 90Y-NZ-16 therapy improves efficacy and reduces toxicity in pleural mesothelioma mice.

  2026cites this paper
• Impact of hyperthermic intrathoracic chemotherapy during cytoreductive surgery with diaphragmatic resection.

  2025cites this paper
• Perioperative Treatments in Pleural Mesothelioma: State of the Art and Future Directions

  2025influential citation
• Surgical treatment for pleural mesothelioma with hyperthermic intrathoracic chemotherapy: a clinical case

  2025cites this paper
• The Evolving Role of Chemotherapy in the Management of Pleural Malignancies: Current Evidence and Future Directions

  2025cites this paper
• BRCA1-Associated Protein 1 and Enhancer of Zeste Homolog 2: Pathway Interaction and Therapeutic Intervention in Breast Cancer, Mesothelioma, and Lymphoma.

  2025cites this paper
• Hyperthermic Intrathoracic Chemoperfusion and the Role of Adjunct Immunotherapy for the Treatment of Pleural Mesothelioma

  2025cites this paper
• Hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma after cytoreductive surgical procedures: a systematic review

  2025cites this paper
• Dose-Dependent Concentration and Penetration Depth of Cisplatin in Human Lung Tissue During Hyperthermic Exposure

  2025cites this paper
• The Role of Surgery in Pleural Mesothelioma: A Journey through the Evidence, MARS 2 and Beyond

  2025cites this paper
• Hyperthermic Intrathoracic Chemotherapy and Photodynamic Therapy: A Single-Institution Experience for Malignant Pleural Diseases.

  2025cites this paper
• Hyperthermic intrathoracic chemotherapy modulates the immune microenvironment of pleural mesothelioma and improves the impact of dual immune checkpoint inhibition.

  2024cites this paper
• Going to MARS May Shorten Our Patient's Survival.

  2024cites this paper
• Development and In-Vitro Evaluation of Doxorubicin-Loaded Methacrylate Gelatin (GelMa)-Acrylamide Hydrogels for the Treatment of Malignant Pleural Mesothelioma

  2024influential citation
• Effect of intraoperative hyperthermic intrathoracic chemotherapy after pleurectomy decortication for treatment of malignant pleural mesothelioma: a comparative study

  2024cites this paper
• Postoperative early laboratory changes and follow-up process of patients underwent hyperthermic intrathoracic chemotherapy

  2024cites this paper
• The Role of Hyperthermic Intrathoracic Chemotherapy (HITHOC) in Thoracic Tumors

  2024cites this paper
• The Role of Surgery in Pleural Mesothelioma

  2024cites this paper
• Prolonged survival and novel prognostic factors in women with pleural mesothelioma treated with extended pleurectomy decortication

  2024cites this paper
• Multimodal Treatment of Pleural Mesothelioma with Cytoreductive Surgery and Hyperthermic Intrathoracic Chemotherapy: Impact of Additive Chemotherapy

  2024cites this paper
• Mesothelioma: Pleural, Version 1.2024.

  2024cites this paper
• The genetic susceptibility in the development of malignant pleural mesothelioma: somatic and germline variants, clinicopathological features and implication in practical medical/surgical care: a narrative review

  2024cites this paper
• Comparison of video-assisted pleurectomy/decortication surgery plus hyperthermic intrathoracic chemotherapy with VATS talc pleurodesis for the treatment of malignant pleural mesothelioma: A pilot study

  2023cites this paper
• Spare the lung: surgical treatment approach for malignant pleural mesothelioma

  2023cites this paper
• Impact of hyperthermic intrathoracic chemotherapy (HITHOC) during resection of pleural mesothelioma on patient survival

  2023influential citation
• Outcome after cytoreductive surgery combined with hyperthermic intrathoracic chemotherapy in patients with secondary pleural metastases

  2023cites this paper
• Extended pleurectomy/decortication and hyperthermic intraoperative intrapleural cisplatin perfusion for malignant pleural mesothelioma

  2023cites this paper
• High‐dose IV magnesium in mesothelioma patients receiving surgery with hyperthermic intraoperative cisplatin: Pilot studies and design of a phase II randomized clinical trial

  2023cites this paper
• Survival of pleurectomy-decortication and hyperthermic chemotherapy in mesothelioma

  2023cites this paper
• Contemporary issues in the surgical management of pleural mesothelioma

  2023cites this paper
• A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma.

  2022cites this paper
• ERS International Congress 2021: highlights from Assembly 8 Thoracic Surgery and Lung Transplantation

  2022cites this paper
• ERS International Congress 2021: highlights from the Thoracic Surgery and Lung Transplantation Assembly

  2022cites this paper
• Pleurectomy and decortication are associated with better survival for bicavitary cytoreductive surgery for mesothelioma compared with extrapleural pneumonectomy.

  2022cites this paper
• Activation of Adaptive and Innate Immune Cells via Localized IL2 Cytokine Factories Eradicates Mesothelioma Tumors

  2022cites this paper
• Epidemiologie, Diagnostik und Therapie des Pleuramesothelioms

  2022cites this paper
• Development of gelatin methacrylate (GelMa) hydrogels for versatile intracavitary applications.

  2022cites this paper
• Repurposing therapeutics for malignant pleural mesothelioma (MPM) - Updates on clinical translations and future outlook.

  2022cites this paper
• Cytoreductive surgery with hyperthermic intrathoracic chemotherapy for malignant pleural mesothelioma: a systematic review

  2022cites this paper
• Current Management and Future Perspective in Pleural Mesothelioma

  2022cites this paper
• Present and future of hyperthermic intrathoracic chemotherapy (HITHOC) in thoracic surgical oncology

  2021cites this paper
• Landmark Trials in the Surgical Management of Mesothelioma

  2021cites this paper
• Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma—A Prospective Report

  2021cites this paper
• Comparison of VATS Pleurectomy/Decortication Surgery plus Hyperthermic Intrathoracic Chemotherapy with VATS talc pleurodesis for the treatment of Malignant Pleural Mesothelioma: a randomized pilot study

  2021cites this paper
• Occult pleural dissemination detected intraoperatively in patients with thymic tumors: a retrospective analysis

  2021cites this paper
• Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approach

  2021cites this paper
• Cytoreductive Surgery and Hyperthermic Intrathoracic Chemotherapy by Video-Assisted Surgery for Pleural Malignancies. Technical Aspects and Safety Profile from A Single Center

  2021cites this paper
• Hyperthermic Intrathoracic Chemotherapy (HITOC) after Cytoreductive Surgery for Pleural Malignancies—A Retrospective, Multicentre Study

  2021influential citation
• Hyperthermic Intrathoracic Chemotherapy for Malignant Pleural Mesothelioma: The Forefront of Surgery-Based Multimodality Treatment

  2021influential citation
• Cytoreductive Thoracic Surgery Combined with Hyperthermic Chemoperfusion for Pleural Malignancies: A Single-Center Experience

  2021cites this paper
• Hyperthermic intrathoracic chemotherapy in thoracic surgical oncology: future challenges of an exciting procedure.

  2021cites this paper
• A narrative review of hyperthermic intrathoracic chemotherapy for advanced lung cancer

  2021cites this paper
• Assessment of concentration and penetration depth of cisplatin in human lung tissue after decortication and hyperthermic exposure

  2021influential citation
• Hyperthermic Intrathoracic Chemoperfusion for Malignant Pleural Mesothelioma: Systematic Review and Meta-Analysis

  2021influential citation
• A narrative review of current treatment strategies and emerging therapies in malignant pleural mesothelioma

  2021cites this paper
• Cytoreductive Surgery and Hyperthermic Intrathoracic Chemotherapy by Video-Assisted Surgery for Pleural Malignancies: Technical Aspects and Safety Profile

  2021cites this paper
• Hyperthermic intrathoracic chemotherapy (HITHOC) should be included in the guidelines for malignant pleural mesothelioma

  2021cites this paper
• Loco-Regional Treatment with Surgical Intervention in Mesothelioma: What Is the Role of Enhancing Local Control Approaches?

  2021cites this paper
• Hyperthermic intrathoracic chemotherapy (HITHOC): narrative review of the current literature, recommendations and future studies

  2021cites this paper
• Taken Together: Effective Multimodal Approaches for Malignant Pleural Mesothelioma.

  2020cites this paper
• The benefit of surgery on survival for patients with stage 1 and 2 malignant pleural mesothelioma

  2020cites this paper
• Commentary: Winning the battle for local control without losing war for survival against malignant pleural mesothelioma.

  2020cites this paper
• Pleurectomy Decortication in the Treatment of Malignant Pleural Mesothelioma

  2020cites this paper
• Diagnostic Laparoscopy Improves Staging of Malignant Pleural Mesothelioma with Routine PET Imaging.

  2020cites this paper
• Protocol of a retrospective, multicentre observational study on hyperthermic intrathoracic chemotherapy in Germany

  2020cites this paper
• Commentary: Cisplatin-induced nephrotoxicity following cytoreductive surgery and heated intraoperative chemotherapy for malignant pleural mesothelioma.

  2020cites this paper
• Classification and staging of thymoma

  2020cites this paper
• A Phase II Trial of Nivolumab With Chemotherapy Followed by Maintenance Nivolumab in Patients With Pleural Mesothelioma After Surgery: The NICITA Study Protocol.

  2020cites this paper
• Updates in Staging and Management of Malignant Pleural Mesothelioma.

  2020cites this paper
• A Proposed System Toward Standardizing Surgery-based Treatments for Malignant Pleural Mesothelioma, From the Joint NCI-IASLC-MARF Taskforce.

  2019cites this paper
• Treatment of malignant pleural mesothelioma with chemotherapy preceding versus after surgical resection

  2019cites this paper
• Extra-pleural pneumonectomy.

  2019influential citation
• Management of Malignant Pleural Mesothelioma in the Elderly Population

  2019cites this paper
• Multimodale Therapiekonzepte beim malignen Pleuramesotheliom

  2019cites this paper
• Pleurectomy/decortication and hyperthermic intrathoracic chemoperfusion using cisplatin and doxorubicin for malignant pleural mesothelioma.

  2019influential citation
• Hypertherme intrathorakale Chemotherapie in der Thoraxchirurgie

  2019cites this paper
• Expertenempfehlung zur Anwendung der hyperthermen intrathorakalen Chemotherapie (HITOC) in Deutschland

  2019influential citation
• Intracavitary cisplatin-fibrin chemotherapy after surgery for malignant pleural mesothelioma: A phase I trial.

  2019cites this paper
• Adequate nephroprotection reduces renal complications after hyperthermic intrathoracic chemotherapy

  2019cites this paper
• Surgical Cytoreduction and HITOC for Thymic Malignancies with Pleural Dissemination

  2019cites this paper
• Surgery for Malignant Pleural Mesothelioma

  2019cites this paper
• A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma

  2018cites this paper
• Anwendung der hyperthermen intrathorakalen Chemotherapie (HITHOC) in Deutschland

  2018influential citation
• Hyperthermic intrathoracic chemotherapy (HITHOC) in ovarian carcinoma - a propos of a case.

  2018cites this paper
• Pleurectomy/decortication versus extrapleural pneumonectomy: a critical choice.

  2018cites this paper
• Surgery for malignant pleural mesothelioma: an international guidelines review.

  2018cites this paper
• Induction or adjuvant chemotherapy for radical multimodality therapy

  2018cites this paper
• The role of intracavitary therapies in the treatment of malignant pleural mesothelioma.

  2018cites this paper
• Combined modality treatment in mesothelioma: a systemic literature review with treatment recommendations.

  2018cites this paper
• Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival

  2018cites this paper
• Adjuvant, neoadjuvant, and definitive radiation therapy for malignant pleural mesothelioma.

  2018cites this paper
• Intraoperative hypertherme intrathorakale Chemotherapie

  2018cites this paper
• New Concepts in the Treatment of Malignant Pleural Mesothelioma.

  2018cites this paper
• Intracavitary Therapeutics for Pleural Malignancies.

  2018cites this paper
• Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study

  2018cites this paper
• Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.

  2018cites this paper
• Management of Malignant Lung Entrapment, the Oncothorax.

  2018cites this paper
• Malignant Pleural Mesothelioma

  2018cites this paper
• Malignant pleural mesothelioma: some progress, but still a long way from cure.

  2018cites this paper